These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15288279)

  • 1. Old and new markers for breast cancer prognosis: the need for integrated research on quantitative issues.
    Biganzoli E; Boracchi P
    Eur J Cancer; 2004 Aug; 40(12):1803-6. PubMed ID: 15288279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines as tumor markers in breast cancer].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2003; 57(4):455-63. PubMed ID: 14626202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour markers in breast cancer--EGTM recommendations. European Group on Tumor Markers.
    Anticancer Res; 1999; 19(4A):2803-5. PubMed ID: 10470245
    [No Abstract]   [Full Text] [Related]  

  • 6. "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers.
    Edén P; Ritz C; Rose C; Fernö M; Peterson C
    Eur J Cancer; 2004 Aug; 40(12):1837-41. PubMed ID: 15288284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integration of new and future biomarkers in the treatment of breast cancer].
    Würtz SØ; Henriksen KL; Lykkesfeldt A; Celis J; Brünner NA
    Ugeskr Laeger; 2007 Sep; 169(36):2999-3003. PubMed ID: 17953881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic and predictive factors in breast cancer].
    Bozhok AA; Semiglazov VF; Semiglazov VV; Arzumanov AS; Klettsel' AE
    Vopr Onkol; 2005; 51(4):434-43. PubMed ID: 16308974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer.
    Henry NL; Hayes DF
    Oncologist; 2006 Jun; 11(6):541-52. PubMed ID: 16794234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between IL-10 and tumor markers in breast cancer patients.
    Llanes-Fernández L; Alvarez-Goyanes RI; Arango-Prado Mdel C; Alcocer-González JM; Mojarrieta JC; Pérez XE; López MO; Odio SF; Camacho-Rodríguez R; Guerra-Yi ME; Madrid-Marina V; Tamez-Guerra R; Rodríguez-Padilla C
    Breast; 2006 Aug; 15(4):482-9. PubMed ID: 16403632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical markers as predictive tools for breast cancer.
    Walker RA
    J Clin Pathol; 2008 Jun; 61(6):689-96. PubMed ID: 18037665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK.
    Hayes DF; Ethier S; Lippman ME
    Breast Cancer Res Treat; 2006 Nov; 100(2):237-8. PubMed ID: 16773436
    [No Abstract]   [Full Text] [Related]  

  • 14. TIMP-1 as a tumor marker in breast cancer--an update.
    Würtz SO; Schrohl AS; Mouridsen H; Brünner N
    Acta Oncol; 2008; 47(4):580-90. PubMed ID: 18465326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tumor markers in patients with breast cancer.
    Lumachi F; Basso SM
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):921-31. PubMed ID: 15485325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers still off the mark for detecting breast cancer.
    May M
    Nat Med; 2010 Jan; 16(1):3. PubMed ID: 20057389
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinases-1 in breast cancer.
    Würtz SØ; Schrohl AS; Sørensen NM; Lademann U; Christensen IJ; Mouridsen H; Brünner N
    Endocr Relat Cancer; 2005 Jun; 12(2):215-27. PubMed ID: 15947098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.